Keyphrases
In Vitro Activity
100%
Human Cell Lines
100%
Filamentous Fungi
100%
Polyhexamethylene Biguanide
100%
Manuka Honey
100%
Antifungal Activity
66%
Cytotoxicity
50%
Clinical Application
33%
Exposure Time
33%
Treatment Strategy
16%
Soft Tissue
16%
Clinical Care
16%
Human Cells
16%
Osteoblast
16%
Cell Viability
16%
Host Tissues
16%
Lethal Dose 50 (LD50)
16%
Antifungal Therapy
16%
In Vitro Toxicity
16%
Surgical Debridement
16%
Fusarium
16%
Dermal Fibroblasts
16%
Epidermal Keratinocytes
16%
Time-dependent Toxicity
16%
Viability Assay
16%
Invasive Fungal Infection
16%
Parallel for
16%
Time-kill Assay
16%
Honey Concentration
16%
Exophiala
16%
Lichtheimia
16%
Immunology and Microbiology
Cell Line
100%
Human Cell
100%
Filamentous Fungus
100%
Antifungal Activity
100%
Cytotoxicity
75%
Mould
50%
Keratinocyte
25%
Host Tissue
25%
Osteoblast
25%
Cell Viability
25%
Soft Tissue
25%
Exophiala
25%
Lichtheimia
25%
Fibroblast
25%
Fusarium
25%
Medicine and Dentistry
In Vitro
100%
Cell Line
100%
Poly(hexamethylenebiguanide)
100%
Antifungal Activity
66%
Cytotoxicity
50%
Keratinocyte
16%
Cell Viability
16%
Antifungal Therapy
16%
Osteoblast
16%
Debridement
16%
Systemic Mycosis
16%
In Vitro Toxicity
16%
Exophiala
16%
Fibroblast
16%
Pharmacology, Toxicology and Pharmaceutical Science
Filamentous Fungus
100%
Poly(hexamethylenebiguanide)
100%
Antifungal Activity
66%
Cytotoxicity
50%
Mould
33%
In Vitro Toxicity
16%
Cell Viability
16%
Viability Assay
16%
Antifungal Therapy
16%
Systemic Mycosis
16%
Exophiala
16%
Lichtheimia
16%
Fusarium
16%